Neuron-Specific Enolase (NSE) is recognized as a biomarker for small cell lung cancer. It is secreted from neuroendocrine cells as well as neurogenic tumors. Its levels in NSE-secreting neoplasms correlate with tumor mass and tumor metabolic activity. |
Specificity | Human NSE |
Production | Culturedin vitrounder conditions free from animal-derived components |
Purification | Protein A/G affinity column |
Formulation | 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% Proclin 300 |
Clone ID | 19A1 |
Target Background | Neuron-Specific Enolase (NSE) is recognized as a biomarker for small cell lung cancer. It is secreted from neuroendocrine cells as well as neurogenic tumors. Its levels in NSE-secreting neoplasms correlate with tumor mass and tumor metabolic activity. |